Alopecia Treatment Market - Global Forecast to 2026
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1847
In recent past, regulatory bodies have approved novel drugs for treatment of alopecia and many drugs are in pipeline, which are expected to receive approval in near future. Approval of novel drugs and presence of robust drug pipeline is expected to drive global alopecia treatment market growth in near future. For instance, in January 2018, Concert Pharmaceuticals, Inc., a U.S.-based company received Fast Track designation from U.S. Food and Drug Administration (FDA) for its novel product CTP-543. CTP-543 is a novel, oral Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe alopecia areata. In April 2018, Concert Pharmaceuticals, Inc., finished patient recruitment for Phase 2a trial evaluating CTP-543 for the treatment of moderate-to-severe alopecia areata.
In January 2018, HCell Inc., a Texas-based biotechnology company received Orphan Drug Designation (ODD) for HC017AA drug from U.S. Food and Drug Administration (FDA). HC017AA is an underdevelopment drug indicated for non- surgical treatment for Alopecia Areata in Pediatric Patients. In 2016, Galderma Laboratories, L.P., a company focused on development of dermatology and skin health launched its new qilib Hair Regrowth + Revitalization System and qilib Hair Health Reinforcement Biotin + Multivitamin Supplement. The qilib system is indicated for hair regrowth and contains clinically proven, prescription-strength minoxidil specifically formulated for men (5% minoxidil) or women (2% minoxidil). In 2017, Perrigo Company Plc. Launched over-the-counter (OTC) Women's Rogaine 5% minoxidil foam (minoxidil topical aerosol, 5% foam). Women's Rogaine 5% minoxidil foam (minoxidil topical aerosol, 5% foam) is indicated to regrow hair on top of the scalp. The launches of such novel products in market is expected to drive the global alopecia market growth in near future.
Click To Continue Reading @ https://www.coherentmarketinsights.com/market-insight/alopecia-treatment-market-1847
Key players operating in the alopecia treatment market include Histogen, Inc., Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., HCell Inc., GlaxoSmithKline Plc., Daiichi Sankyo, Inc., Cipla Limited, and others.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Visit Blog: https://healthcaremarketconsulting.blogspot.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alopecia Treatment Market - Global Forecast to 2026 here
News-ID: 1100559 • Views: 995
More Releases from Coherent Market Insights
Pulmonary Drug Delivery Systems Market is Booming Growth Prospects, Incredible D …
According to Coherent Market Insights, the global pulmonary drug delivery systems market is estimated to be valued at US$ 34.34 billion in 2023 and is expected to exhibit a CAGR of 4.6% during the forecast period (2023-2030). Pulmonary drug delivery systems are devices used for administering drugs to treat various respiratory diseases like asthma, COPD, and cystic fibrosis. These devices facilitate delivery of drugs directly into the lungs for
Bio-implant Market Emerging Trends, Business Opportunities, Highest Revenue, Boo …
According to Coherent Market Insights, global bio-implant market is estimated to be valued at US$ 91.14 Billion in 2023, exhibiting a CAGR of 6.0% during the forecast period (2023-2030). Bio-implants are medical devices that are placed inside the human body to replace missing biological structures or to enhance body functions. They include orthopedic implants, dental implants, neural implants, cardiac implants, and others. Market Dynamics: The growing awareness regarding the benefits of
Agricultural Microbials Market With Included Analysis of New Trends, Updates, an …
The Agricultural Microbials Market is estimated for 2023 for the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Agricultural microbials are microorganisms such as bacteria, fungi, or viruses that are used to enhance plant growth and reduce crop disease. They improve soil health and quality by nutrient recycling and suppression of plant pathogens. Market Dynamics: The agricultural microbials market is expected to witness significant growth over
Textile Chemicals Market Size, Share & Trends Analysis, Growing Industry Demand, …
Market Overview: Textile chemicals are used in textile processing such as pre-treatment, dyeing, printing and finishing. This includes chemicals used for washing, bleaching, sizing and other purposes. Textile chemicals enhance properties such as wrinkle resistance, water absorption and provides other functional properties to fabrics. Market Dynamics: The global textile chemicals market is witnessing high growth owing to rising demand for textile chemicals from emerging economies such as China, India and Brazil. These countries
More Releases for Alopecia
Global Alopecia Market By Disease type: Alopecia Areata, Cicatricial, Traction, …
According to the latest research by SkyQuest Technology, Global Alopecia Market Size was valued at US$ 8.7 billion in 2021, and it is expected to reach a value of US$ 15.10 billion by 2028, at a CAGR of 8.2% over the forecast period (2022 - 2028). The research provides up-to-date Alopecia Market analysis of the current market landscape, latest trends, drivers, and overall market environment. Get full report : https://skyquestt.com/report/alopecia-market The rising
Alopecia Market Research Report Up to 2031
Visiongain has published a new report on Alopecia Market Report to 2031: Forecasts by Disease Type (Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, and Alopecia Totalis), By Route of Administration (Oral, Topical, and Injectable), By Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies) PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/alopecia-market/#download_sampe_div COVID-19 Impact on Alopecia Market COVID-19 pandemic has affected more than 200 countries worldwide. Companies have been pressured
Researchers Discover Potential of Alopecia Treatment Market
The Alopecia Treatment Market report gives a weighty source to assess the market and other fundamental technicalities identifying with it. The examination unveils the total assessment and veritable parts of the Alopecia Treatment Market. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report.The trends and expected prospects for
Alopecia Drugs Market Outlook till 2018 to 2022 | By Alopecia Type Alopecia Area …
Market Research Future Published a Prime Research Report on Global Alopecia Drugs Market. The global Alopecia Drugs Market is expected to grow at a CAGR of 6.92% during the Period 2018 to 2022. “Alopecia Drugs Market” Completed Major Study of Alopecia Drugs in Market Research Future. This Report aim is Provide Insights about Factors Affecting the Market Growth. Market Scenario of Global Alopecia Drugs Market: Alopecia is loss of hair due to a
Alopecia Treatment Market - Global Forecast to 2026
Alopecia also called as hair-loss or baldness is a medical condition that refers to loss of hairs from head or any part of the body. The condition can occur in both male and female and at any age. There are five major type of alopecia namely; alopecia areata, androgenic alopecia, ciatricial alopecia, traction alopecia, and alopecia totalis. Alopecia areata is a common autoimmune disorder in which the immune system of
Alopecia-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Alopecia-Pipeline Review H2 2017” this report provides an overview of the Alopecia (Dermatology) pipeline landscape. Alopecia is the partial or complete loss of hair especially on the scalp either in patches on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies irritants toxins burns injuries and infections. Report Highlights Pharmaceutical and Healthcare latest pipeline